Trial intelligence / Profile preview

Esketamine Combined With Pregabalin for Acute Postoperative Pain in Spinal Neoplasm Surgery

NCT05096468Phase 3Completed

Sponsor
Beijing Tiantan Hospital
Start
Dec 2021
Primary completion
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of esketamine, pregabalin in acute postoperative pain, sponsored by Beijing Tiantan Hospital. Started Dec 2021; status: completed.

02

Drugs

esketaminepregabalin
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on NCT05096468.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05096468.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call